Stephen Mayo Net Worth & Insider Trades

Stephen Mayo - Director, Sarepta Therapeutics, Inc

As of March 8, 2023

What is Stephen Mayo's Net Worth?

The current estimated net worth of Sarepta Therapeutics, Inc's Director, Stephen Mayo, is estimated to be about $925.1K . Stephen Mayo owns about 6,387 units of Sarepta Therapeutics, Inc common stock. In the last 2 years at Sarepta Therapeutics, Inc, Stephen Mayo has sold an estimated value of $94.31K worth.

What is Stephen Mayo's Past Insider Trading?

Stephen Mayo's largest sale order was 858 units , worth over $94.31K on November 21, 2022. In total, Stephen Mayo has made about 4 transactions over 2 years of their time at Sarepta Therapeutics, Inc. Stephen Mayo usually trades in November and March, with the busiest year in 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Stephen Mayo's' Mailing Address?

  • Mailing address is 2000 Galloping Hill Rd Kenilworth NJ 07033 NJ

Sarepta Therapeutics, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
Douglas S. Ingram 2020 $669,250 - $17,222 $17,222 $17,222 $1,291,947
Douglas S. Ingram 2019 $650,000 - $5,822 $5,822 $5,822 $1,387,072
Douglas S. Ingram 2018 $650,000 - $5,822 $5,822 $5,822 $1,433,872
Ian M. Estepan 2020 $445,822 $434,986 $32,744 $32,744 $32,744 $5,177,681
Ian M. Estepan 2019 - - - - - -
Ian M. Estepan 2018 - - - - - -
Gilmore O'Neill, M.B., M.M.Sc. 2020 $583,277 $766,949 $15,500 $15,500 $15,500 $3,790,049
Gilmore O'Neill, M.B., M.M.Sc. 2019 $563,962 - $15,300 $15,300 $15,300 $5,168,110
Gilmore O'Neill, M.B., M.M.Sc. 2018 $310,962 $1,154,760 $2,050 $2,050 $2,050 $6,449,176
William Ciambrone 2020 $458,179 - $14,500 $14,500 $14,500 $679,938
William Ciambrone 2019 $51,346 - $1,000 $1,000 $1,000 $4,345,194
William Ciambrone 2018 - - - - - -
Louise Rodino-Klapac, Ph.D. 2020 $495,590 $766,949 $13,532 $13,532 $13,532 $7,269,509
Louise Rodino-Klapac, Ph.D. 2019 - - - - - -
Louise Rodino-Klapac, Ph.D. 2018 - - - - - -
Joseph Bratica 2020 $326,028 $237,525 $11,645 $11,645 $11,645 $911,887
Joseph Bratica 2019 - - - - - -
Joseph Bratica 2018 - - - - - -
Sandesh Mahatme 2020 $312,835 $766,949 $39,413 $39,413 $39,413 $3,364,021
Sandesh Mahatme 2019 $557,327 - $14,840 $14,840 $14,840 $5,161,209
Sandesh Mahatme 2018 $498,112 - $24,838 $24,838 $24,838 $4,219,084
David Tyronne Howton, Jr. 2020 $470,695 $1,050,929 $157,280 $157,280 $157,280 $5,703,078
David Tyronne Howton, Jr. 2019 $458,844 - $13,318 $13,318 $13,318 $4,196,622
David Tyronne Howton, Jr. 2018 $438,185 - $13,118 $13,118 $13,118 $3,129,375
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/873303/000156459021019631/srpt-def14a_20210603.htm

What are Sarepta Therapeutics, Inc's Past Insider Trades?

Sarepta Therapeutics, Inc's most recent insider trade came on November 21, 2022 by Stephen Mayo who sold 858 units worth $94.31K . In the last 10 years, insiders at Sarepta Therapeutics, Inc have sold an estimated value of $177.5M and bought an estimated value of $53.33M worth of shares. Insider trading is most common in March, with the busiest year in 2017. The most active traders at the company are Sandesh Mahatme, EVP,  David T Howton, EVP,  and Edward M. Kaye, Director .

Sarepta Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...